Sponsored
released by
Cardinal Health
05.22.24
Drug Discovery And Development
News Releases
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Cold Chain Management | Laboratory Testing | Process Validation | Serialization
PDUFA to Patients in 7 Days with Integrated Packaging Solutions
Join industry experts on June 20th for an engaging webinar focused on streamlining new drug launches with integrated packaging solutions.
-
Formulation Development | Process Development | Scale-up/Technology Transfer
Three Key Considerations of Complex Liquid Formulations
In this white paper, we delve into three key factors that affect your product across its lifecycle.05.13.24
-
Clinical Trials | Supply Chain
Clinical Trial Modernization - Optimizing the Supply of Decentralized Studies
What are some key supply considerations that sponsors need to keep in mind when planning a DCT? What should they look out for when choosing a supply partner?
-
Drug Delivery
The New Bespak: Championing Sustainability with Chris Hirst
He talks to us about key developments in the inhalation industry and how the formation of a leading global CDMO can provide support in navigating these changes.
-
Biologics, Proteins, Vaccines | Drug Development | Process Development | Scale-up/Technology Transfer
Prepared for the Next Pandemic - Utilizing New Production Capacities for Streamlined Vaccine Mfg
This informative webinar on May 28th will delve into the critical aspects of pandemic preparedness, focusing on vaccine development and production.
-
Injectables | Laboratory Testing
![[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing](https://images.rodpub.com/images/305/150_thumb.jpg)
[WEBINAR] Headspace Gas Ingress Methods - The Golden Tool for Container Closure Integrity Testing
This webinar will cover how headspace methods are developed and validated for a variety of product-container configurations including pre-filled syringes.
-
Clinical Trial Materials | Clinical Trials | Supply Chain
![[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model](https://images.rodpub.com/images/305/148_thumb.jpg)
[WEBINAR] Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
-
Biologics, Proteins, Vaccines
Host Cell DNA Assay Re-Development and Qualification for a PEGylated Protein Drug Substance
Biologic drugs must ensure that DNA from the host cell (hc) is below a recommended limit set by the FDA.04.10.24
-
Biologics, Proteins, Vaccines
Isolation and Characterization of Product-Related Variants in Biotherapeutics
Biotherapeutics comprise a diverse class of protein-based drugs with intricate structural and functional characteristics.04.10.24
-
Biologics, Proteins, Vaccines | Biosimilars
Real-Time Kinetic Data in the Successful Dev of an Inhibition of Proliferation Potency Bioassay
The quantitative measurement of potency plays a critical role in biopharmaceutical development.04.10.24
-
APIs | Capsules | Drug Development | Formulation Development | R&D | Scale-up/Technology Transfer
Why Sofgen Pharmaceuticals?
Integrated services in development, scale up, commercial manufacturing and packaging.04.04.24
-
cGMP Manufacture | Drug Development | Drug Discovery | Preclinical Outsourcing | Process Development
-
Analytical Services | Bioanalytical Services | Drug Delivery | Laboratory Testing
Solvias: Providing Cutting-Edge Expertise in Orally Inhaled and Nasal Drug Products
A Q&A with Yannick Baschung, team leader for drug delivery and physical characterization services at Solvias.
-
Biologics, Proteins, Vaccines | R&D
An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market
The demand for biologic drugs continues to grow at a steady 12–14% annually.
-
Analytical Services | Process Development | R&D
Explore USP’s State-of-the-Art Facilities
Extensive scientific expertise and state-of-the-art facilities support analytical dev needs for continuous flow from R&D and process dev through mfg.Videos01.03.24
-
APIs | Bioanalytical Services | Biologics, Proteins, Vaccines
Build Quality into Biopharmaceutical Processes with Real-Time Monitoring and Control
The ability to monitor biopharma processes in real time provides significant advantages in optimizing product quality with respect to multiple attributes.
-
APIs | Biologics, Proteins, Vaccines | Drug Development
![No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents [WATCH ON-DEMAND]](https://images.rodpub.com/images/287/117_thumb.jpg)
No More DMF: Greener Solid-Phase Peptide Synthesis With Binary Solvents [WATCH ON-DEMAND]
Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.
-
Drug Development | Extractables and Leachables | Process Development
The True Cost of Inadequate Extractables & Leachables Testing
E&L assessments are vital to ensure patient safety and consistent product quality.11.27.23
-
Drug Development | Solid Dosage/Creams/Ointments
Contracting & Outsourcing 2023: Q&A with Hibre Terefe of Catalent
Director of R&D discusses OSD capabilities and technologies at Catalent's Somerset CoE site.Videos11.22.23
-
Biologics, Proteins, Vaccines | Fill/Finish
Contracting & Outsourcing 2023: Q&A with John Bertagnolli of Selkirk
Vice President of Commercial Operations shares insight on industry trends, successful partnerships, and the company's new facility.Videos11.20.23
